CTOs on the Move

Chimerix

www.chimerix.com

 
Chimerix is a biopharmaceutical company dedicated to discovering, developing and commercializing medicines that improve outcomes for immunocompromised patients. Chimerix`s proprietary lipid conjugate technology has produced brincidofovir (BCV, CMX001); CMX157, which was licensed to ContraVir Pharmaceuticals; and earlier-stage clinical candidates. Chimerix recently announced a new clinical candidate, CMX521, for the treatment and/or prevention of norovirus.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million
  • www.chimerix.com
  • 2505 Meridian Parkway Suite 100
    Durham, NC USA 27713
  • Phone: 919.806.1074

Executives

Name Title Contact Details
Roy Ware
 Chief Manufacturing and Technology Officer Profile

Funding

Chimerix raised $100M on 01/21/2021

Similar Companies

NeurAbilities Healthcare

The premier provider of comprehensive and coordinated neurological and behavioral services in New Jersey and Pennsylvania, offering comfort, hope and answers that transform individuals and their families.

Distalmotion

Establishing a new standard of care, where all patients in general surgery, gynecology and urology have access to optimal minimally invasive care.

Pharm-Aloe Inc

Pharm-Aloe Inc is a Woodford, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pharmetics

Pharmetics is a Laval, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Provectus Biopharmaceuticals

Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus` investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers.